LUCIUS 卢修斯 恩西地平 Enasidenib白血病

恩西地平

美国FDA批准上市产品,疗效确切
卢修斯制药(老挝)有限公司出品

Enasidenib

老挝国家食药监局批准上市
老挝国家药检所检测认证

Composition:

LUCiUS

白血病

Each tablet contains: Enasidemb ......... 50mg

PHARMACEUTICALS

Luciena is an isocitrate dehydrogenase-2
inhibitor indicated for the treatment of adul
patients with relapsed or refractory aeuta
mveloid leukemia (AML. with an isocitra
dehydrogenase-2(IDH21mutation.

LUCIENA

The recommended dosage of LuciEna is 100 mg
taken orally once darly with or without food
tnr dscase progression or unacceptable
toxicity,

Enasidenib Tablets

FDA批准

Tablet should be swallowed whole & not

chewed or crchad
Storaoorinadrenlacea
adry place and store at 20C. fo 25℃ ...

50mg

Keep medicine out of the reach of Children.
Do not administered LuciEna in Preona
and Lactation natient treatment.
PLEASE SEE PACKAGE INSERT
Manufactured and Marketed by
LUCIUS

权威认证

Thongmang village. Xavthany district
ientiane Capital, Laos
warning : 1o be sold by retatl on prescription
of a Kegistered oncologist only, and as directed
by the physician

30
Tablets

Rx Only

口碑质量

适应症:

用于治疗复发或难治性急性髓系白血病(AML)的

成年患者。

推荐剂量:

每日口服一次,每次100 mg,直到疾病进展或出现
不可接受的毒性。